Endocrine alterations with amiodarone therapy

A. Krasner, A. S. Dobs

Research output: Contribution to journalArticlepeer-review

Abstract

Candidates for amiodarone therapy should undergo endocrine screening. This antiarrhythmic agent has been associated with hypothyroidism, hyperthyroidism, and, recently, testicular dysfunction. Hypothyroidism can usually be treated with thyroxine replacement however, therapy for hyperthyroidism usually centers on withdrawing the drug and administering antithyroid agents. Testosterone supplementation should be considered for patients with testicular dysfunction.

Original languageEnglish (US)
Pages (from-to)32-34+39
JournalPrimary Cardiology
Volume19
Issue number3
StatePublished - Jan 1 1993

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Endocrine alterations with amiodarone therapy'. Together they form a unique fingerprint.

Cite this